Exane Derivatives’s Bank of Montreal BMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-250
Closed -$1.83K 679
2018
Q4
$1.83K Hold
250
﹤0.01% 528
2018
Q3
$2 Hold
250
﹤0.01% 691
2018
Q2
$4 Buy
+250
New +$19.2K ﹤0.01% 683
2017
Q1
Sell
-650
Closed -$806K 585
2016
Q4
$806K Hold
650
0.16% 102
2016
Q3
$333K Buy
+650
New +$42.2K 0.05% 174
2016
Q2
Sell
-650
Closed -$176K 561
2016
Q1
$176K Buy
+650
New +$35.6K 0.02% 202
2015
Q4
Sell
-900
Closed -$151K 530
2015
Q3
$151K Hold
900
0.02% 201
2015
Q2
$201K Hold
900
0.02% 210
2015
Q1
$315K Sell
900
-250
-22% -$15.5K 0.03% 172
2014
Q4
$871K Buy
+1,150
New +$82.3K 0.12% 104

Other funds holding BMO

Exane Derivatives's BMO Position: Q2 2022 in Review

Exane Derivatives sold out of Bank of Montreal (BMO) in Q2 2022, closing a stake of 65 shares — an estimated $7.64K sold.

Exane Derivatives first reported a position in BMO in Q1 2017 and held it in 18 quarters. The position peaked at $2.52M in Q4 2017. 487 funds tracked by Wall St. Rank hold BMO as of Q2 2022.

  • Exane Derivatives reported no remaining Bank of Montreal position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 65 Bank of Montreal shares in Q2 2022, an estimated $7.64K.
  • Exane Derivatives first reported a position in Bank of Montreal in Q1 2017 and held it in 18 quarters.
  • Exane Derivatives's Bank of Montreal position peaked at $2.52M in Q4 2017.
  • 487 funds tracked by Wall St. Rank held Bank of Montreal as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.